4//SEC Filing
MacFarlane Katie 4
Accession 0001493152-20-014585
CIK 0000849636other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 2:28 PM ET
Size
5.3 KB
Accession
0001493152-20-014585
Insider Transaction Report
Form 4
MacFarlane Katie
Director
Transactions
- Award
Common Stock Options (to purchase shares of Common Stock)
2020-07-31+7,500,000→ 7,500,000 totalExercise: $0.01Exp: 2025-07-31→ Common Stock (7,500,000 underlying)
Footnotes (1)
- [F1]These Common Stock Options vested upon issuance.
Documents
Issuer
RespireRx Pharmaceuticals Inc.
CIK 0000849636
Entity typeother
Related Parties
1- filerCIK 0001608535
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 2:28 PM ET
- Size
- 5.3 KB